In case you missed it: June 27 to July 1
A look back at the week's news.
Not just abortion: How the demise of Roe v Wade may impact fertility care
As we were going to press with the July issue, the United States Supreme Court overturned Roe v Wade, eliminating the constitutional right to an abortion, and leaving the question of abortion rights to the states.
Pharmacies limiting Plan B purchases after Roe v. Wade reversal
The American Medical Association is urging the FDA to approve OTC access to oral contraceptives.
HHS secretary details department’s efforts to protect reproductive health care
“The impact was visible and real,” said Xavier Becerra, secretary of the US Department for Health and Human Services during a press conference Tuesday.
SOGH responds to Roe v Wade decision
The Society of Ob/Gyn Hospitalists released a statement on the Supreme Court Decision overturning Roe v Wade.
Cesarean delivery reduces mortality risk in preterm breech births
December 2nd 2024In a recent study, infants born very preterm or extremely preterm had reduced odds of mortality when cesarean delivery was chosen as the mode of delivery, without a notable increase in any morbidity risk.
Read More
Emerging multiplex UTI testing drives Medicare costs amid increased utilization
November 27th 2024A recent study found a sharp rise in Medicare claims for multiplex urinary tract infection testing from 2016 to 2023, underscoring a significant financial impact and the need for further research into its clinical benefits.
Read More
